人类疫苗和免疫疗法 SCIE

期刊简介预计审稿时间： 一般,3-6周

(formerly Human Vaccines; issn 1554-8619)

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.

（原名人类疫苗；issn 1554-8619）

疫苗研究和开发的范围正在扩大，不再仅限于预防细菌或病毒性疾病。目前已有用于免疫治疗目的和传染病之外的应用的实验性疫苗，可用于癌症、自身免疫、过敏、阿尔茨海默氏症和成瘾等不同领域。许多此类疫苗和免疫疗法应在未来二十年内上市，从而造福人类健康。该领域的持续进步将受益于一个论坛，该论坛可以 (A) 通过让研究人员了解最新情况来帮助促进人们的兴趣，并且 (B) 就与疫苗和免疫疗法相关的许多主题的最新进展交换意见。

《人类疫苗与免疫疗法》提供了这样一个论坛。它每月出版一次，形式广泛，学术、工业和公共部门的国际读者都可以阅读。

《Human Vaccines & Immunotherapeutics》(人类疫苗和免疫疗法)编辑部通讯方式为530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。